PMC:7299399 / 33048-33615
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T161 | 56-69 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
| T162 | 491-495 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T42 | 56-69 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T124 | 140-160 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
| T125 | 276-296 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T300 | 56-69 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T301 | 228-231 | http://purl.obolibrary.org/obo/CLO_0054060 | denotes | 102 |
| T302 | 314-323 | http://purl.obolibrary.org/obo/OBI_0100026 | denotes | organisms |
| T303 | 314-323 | http://purl.obolibrary.org/obo/UBERON_0000468 | denotes | organisms |
| T304 | 473-474 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T305 | 491-495 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T306 | 520-521 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T239 | 416-421 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T29 | 105-111 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T128 | 0-346 | Sentence | denotes | Finally, the indiscriminate systemic suppression of the immune system may increase the susceptibility to sepsis due to underlying secondary bacterial infections that can exacerbate critical conditions in patients, causing death.102 Risk factors for mortality include acquired bacterial infections by opportunistic organisms and primary pathogens. |
| T129 | 347-567 | Sentence | denotes | Using nanocarriers to achieve targeted delivery of immunosuppressive drugs, or the specific and controlled inhibition of only a specific immune cell subpopulation, can play a critical role in limiting such complications. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 535 | 204-212 | Species | denotes | patients | Tax:9606 |
| 536 | 13-27 | Chemical | denotes | indiscriminate | |
| 537 | 105-111 | Disease | denotes | sepsis | MESH:D018805 |
| 538 | 150-160 | Disease | denotes | infections | MESH:D007239 |
| 539 | 222-227 | Disease | denotes | death | MESH:D003643 |
| 540 | 249-258 | Disease | denotes | mortality | MESH:D003643 |
| 541 | 276-296 | Disease | denotes | bacterial infections | MESH:D001424 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-32171076-158526 | 228-231 | 32171076 | denotes | 102 |